GSA Capital Partners’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $328K | Sell |
57,177
-2,338
| -4% | -$13.4K | 0.02% | 1201 |
|
|
2025
Q1 | $486K | Sell |
59,515
-22,826
| -28% | -$186K | 0.04% | 824 |
|
|
2024
Q4 | $776K | Sell |
82,341
-51,459
| -38% | -$485K | 0.06% | 580 |
|
|
2024
Q3 | $1.43M | Buy |
133,800
+83,081
| +164% | +$887K | 0.11% | 250 |
|
|
2024
Q2 | $503K | Buy |
+50,719
| New | +$503K | 0.04% | 960 |
|
|
2023
Q1 | – | Sell |
-21,181
| Closed | -$259K | – | 1610 |
|
|
2022
Q4 | $259K | Buy |
+21,181
| New | +$259K | 0.03% | 1030 |
|
|
2022
Q3 | – | Sell |
-12,023
| Closed | -$129K | – | 1638 |
|
|
2022
Q2 | $129K | Buy |
+12,023
| New | +$129K | 0.02% | 1177 |
|
|
2021
Q4 | – | Sell |
-112,813
| Closed | -$1.08M | – | 1531 |
|
|
2021
Q3 | $1.08M | Buy |
+112,813
| New | +$1.08M | 0.11% | 279 |
|
|
2021
Q2 | – | Sell |
-56,077
| Closed | -$554K | – | 1400 |
|
|
2021
Q1 | $554K | Buy |
+56,077
| New | +$554K | 0.09% | 294 |
|
|
2020
Q4 | – | Sell |
-41,952
| Closed | -$592K | – | 1329 |
|
|
2020
Q3 | $592K | Buy |
+41,952
| New | +$592K | 0.1% | 302 |
|
|
2019
Q4 | – | Sell |
-13,370
| Closed | -$107K | – | 1523 |
|
|
2019
Q3 | $107K | Buy |
+13,370
| New | +$107K | 0.01% | 1267 |
|
|
2017
Q4 | – | Sell |
-20,506
| Closed | -$309K | – | 1638 |
|
|
2017
Q3 | $309K | Buy |
+20,506
| New | +$309K | 0.02% | 1224 |
|